SurgLine International FCF per Share
Free Cash Flow per Share of SurgLine International (SGLN) as of Nov 4, 2026.
Get this data via API
Financial Data API
FCF per Share
-0.00USD
Last updated:
Free Cash Flow per Share of SurgLine International is 2012 -0.00 USD. Free Cash Flow per Share of SurgLine International was 2011 - USD. It decreases by % lower compared to the previous year.
The SurgLine International FCF per Share history
| YEAR | FCF per Share | YoY |
|---|---|---|
| -0.00USD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
SurgLine International Stock analysis
What does SurgLine International do? SurgLine International Inc is a US-American company founded in 2011. The company focuses on the development and manufacturing of medical devices, particularly implants and instruments for orthopedic and spinal surgery. SurgLine International is headquartered in Tampa, Florida, and operates subsidiaries in Europe, Asia, and South America.
The founders of SurgLine are medical professionals who have practiced in the field of orthopedics and spinal surgery for many years. They have a vision to revolutionize orthopedic surgery worldwide by combining technology, experience, and knowledge. SurgLine's business model is to manufacture and distribute innovative medical products that meet the highest standards of quality, safety, and effectiveness at a fair price.
SurgLine offers several product lines:
- SurgLine Proline™ is an implant line developed in close collaboration with leading orthopedic surgeons. The Proline implants are made from high-quality materials that are both stable and biocompatible. SurgLine offers a wide selection of implants for hip, knee, shoulder, wrist, ankle, and foot joints.
- The SurgLine instrumentarium consists of a variety of surgical instruments that assist surgeons during operations. The instruments are made from high-quality stainless steel or titanium, are reusable, and have been designed to meet the requirements of orthopedic surgery. SurgLine also offers instruments for spinal surgery.
- SurgLine also distributes third-party products and is a distribution partner for other medical technology companies. This allows the company to offer a broader portfolio and provide customers with even better solutions.
One of SurgLine's strengths is its ability to innovate and be flexible. The company is able to quickly respond to market needs and develop new products in a short period of time. In recent years, the company has introduced a range of innovative implants and instruments that enable surgeons to perform more successful and effective operations.
SurgLine is also very competitive in terms of pricing. The company has an efficient business model that enables it to offer products at a fair price without compromising on quality. This has helped SurgLine quickly enter the global market and become a key player in the medical technology industry.
To distribute its products, SurgLine works closely with a variety of distribution partners, including distributors and medical professionals worldwide. The company is constantly seeking new distribution partners and sales representatives to bring its products to new markets and attract more customers.
The future of SurgLine looks promising as the company is working on numerous projects to expand its product range. SurgLine's goal is to continue being an innovative partner for all orthopedic and spinal surgeons seeking safer and more effective solutions. SurgLine International is one of the most popular companies on Eulerpool.
Frequently Asked Questions about SurgLine International stock
On Eulerpool you can find the complete historical development of Free Cash Flow per Share SurgLine International since 2006 – with annual values, charts, and detailed analysis.
FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Cash Flow — SurgLine International
Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A
All Key Metrics — SurgLine International
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth